טוען...
The Sodium Iodide Symporter (NIS): Regulation and Approaches to Targeting for Cancer Therapeutics
Expression of the sodium iodide symporter (NIS) is required for efficient iodide uptake in thyroid and lactating breast. Since most differentiated thyroid cancer expresses NIS, β-emitting radioactive iodide is routinely utilized to target remnant thyroid cancer and metastasis after total thyroidecto...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3408573/ https://ncbi.nlm.nih.gov/pubmed/22750642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2012.06.007 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|